#1
|
|||
|
|||
ÊÎÊ
×òî äåëàòü ñ äåïðåññèåé, âîçíèêøåé íà ôîíå ïðèåìà ÊÎÊ?
ãäå-òî ÷èòàëà, ÷òî äåïðåññèÿ âîçíèêàåò â ðåçóëüòàòå âîçíèêàþùåãî ïî ïðè÷èíå òîãî æå ÊÎÊ äåôèöèòà âèò ãðóïïû Â. Ïðè÷èíà â ýòîì? |
#2
|
|||
|
|||
òîëüêî íå ïðåäëàãàéòå ìîäèôèöèðîâàòü êîíòðàöåïòèâû äîáàâëåíèåì Â.
Ñ òî÷êè çðåíèÿ ýíäîêðèíîëîãèè (òåîðèÿ, íå ïîäòâåðæäåííàÿ íà ïðàêòèêå) ÎÊ óâåëè÷èâàÿ óðîâåíü ÑÑÑÃ, óìåíüøàþò áèîäîñòóïíûé òåñòîñòåðîí, êîòîðûé, ïðåäïîëîæèòåëüíî, è "îòâå÷àåò" çà àêòèâíóþ æèçíåííóþ ïîçèöèþ. Ê ñ÷àñòüþ, íå òîëüêî â òåñòîñòåðîíå äåëî. |
#3
|
|||
|
|||
Ïî ìîèí íàáëþäåíèÿì (íàäî áû ïîèñêàòü èññëåäîâàíèÿ íà ýòó òåìó) äåïðåññèÿ ïðîõîäèò â òå÷åíèè 3-õ ìåñÿöåâ, òî åñòü â òå÷åíèè ïåðèîäà àäàïòàöèè, à òàê æå äåïðåññèÿ ó ïàöèåíòîâ âûðàæåíà áîëüøå ó òåõ ïàöèåíòîâ, êîòîðûå áûëè ê íåì ïðåäðàñïîëîæåíû èçíà÷àëüíî, íî ýòî è òàê ïîíÿòíî:-)
|
#4
|
|||
|
|||
âîò íàøëà ññûëêè íà íåêîòîðûå èññëåäîâàíèÿ
"In a small, placebo-controlled, double-blind clinical trial performed in Manila and Edinburgh focusing on mood as a primary outcome, use of combined oral contraceptives was associated with "modest" negative effects on mood.[1] In a small, 6-cycle study of an OC containing 20 mcg estrogen and 100 mcg levonorgestrel (Alesse, Levlite), 1 of 32 women discontinued due to "intolerable mood changes."[2] In a large (N = 2894), 13-cycle study, 0.5% of participants randomized to an OC containing 25 mcg estrogen and triphasic norgestimate (Ortho Tri-Cyclen Lo) discontinued OC use due to emotional lability; the corresponding percentage with those randomized to 20 mcg estrogen combined with 1 mg norethindrone acetate (Loestrin Fe 1/20) was 0.3%.[3]" [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#5
|
|||
|
|||
Õîðîøî.
2- âîïðîñ ïî ÊÎÊ: åñëè ÷åðåç 12 äíåé ïðèåìà ÊÎÊ â ðåçóëüòàòå ïðîïóñêà 3 òàáë. âîçíèêëà ÌÏÐ, êîãäà ñíîâà ìîæíî íà÷àòü ïðèåì ÊÎÊ (ñ ýòîé ÌÏÐ èëè æäàòü ñëåäóþùóþ ìåíñòðóàöèþ)? 3- êàêàÿ ðàçíèöà ñ êàêîãî äíÿ íà÷èíàòü ïðèåì ÊÎÊ ñ 1 èëè 5? È ìîæíî ëè íà÷èíàòü ïðèåì ÊÎÊ íå íà 1, à íà 2,3,4? |
#6
|
||||
|
||||
Öèòàòà:
2) Ïåðâè÷íûé ïðè¸ì òàáëåòîê íà÷èíàåòñÿ â òå÷åíèå 5 äíåé ïîñëå ìåíñòðóàöèè - â ýòîì ñëó÷àå êîíòðàöåïòèâíûé ýôôåêò îáåñïå÷èâàåòñÿ óæå â ïåðâîì öèêëå è íå òðåáóåòñÿ äîïîëíèòåëüíûõ ìåð ïî êîíòðàöåïöèè. Åñëè ïåðâàÿ òàáëåòêà ïðèíÿòà ïîçäíåå, ÷åì ÷åðåç ïÿòü äíåé ïîñëå íà÷àëà ìåíñòðóàöèè, â ïåðâîì öèêëå ïðè¸ìà ÊÎÊ òðåáóåòñÿ äîïîëíèòåëüíàÿ êîíòðàöåïöèÿ ñðîêîì íà 7 äíåé. |
#7
|
|||
|
|||
1- ïîñëå ïðîïóñêà òðåõ òàáëåòîê ïðèåì ìîæíî íà÷àòü â ëþáîé äåíü, åñëè åñòü óâåðåííîñòü, ÷òî íåò áåðåìåííîñòè è åñëè åñòü ïîòðåáíîñòü â ñêîðåéøåé êîíòðàöåïöèè. Ïðàâäà ïðè ýòîì ñëåäóåò èñïîëüçîâàòü äîïîíèòåëüíûå ìåòîäû êîíòðàöåïöèè â òå÷åíèè 7 äíåé.
2 - ÂÎÇ ñ÷èòàåò, ÷òî ïåðâûå ñåìü äíåé ì.ö. áåçîïàñíû äëÿ íà÷àëà ïðèåìà ÊÎÊ, îäíàêî åñëè ìåíñòðóàöèÿ çàêîí÷èëàñü ðàíüøå 7-ãî äíÿ è äî íà÷àëà ïðèåìà ïåðâîé òàáëåòêè, òî ñëåäóåò ïðèìåíÿòü äîïîëíèòåëüíûå ìåðû êîíòðàöåïöèè â òå÷åíèè íåäåëè. |
#8
|
|||
|
|||
Åñëè íà 6,7 èëè 8 äåíü ÌÖ òîëùèíà ýíäîìåòðèÿ íå áîëåå 5 ìì, ìîæíî ëè íà÷àòü ïðèíèìàòü ÊÎÊ?
|
#9
|
||||
|
||||
Öèòàòà:
|
#10
|
|||
|
|||
Ýòî â ñëó÷àå, åñëè â ïåðâûå 5 äíåé ÌÖ ïàöèåíòêà çàáûëà ïðèíÿòü ÊÎÊ.
|
#11
|
|||
|
|||
ñìîòðèòå âûøå - ìîæíî íà÷àòü ïðèåì â òå÷åíèè ïåðâûõ ñåìè äíåé ì.ö. áåç äîïîëíèòåëüíîãî ïðåäîõðàíåíèÿ åñëè â òå÷åíèè ýòèõ 7 äíåé íå ïðåêðàòèëàñü ìåíñòðóàöèÿ, åñëè ïðèåì íà÷àò ïîñëå ïðåêðàùåíèÿ - òî ïîòðåáóåòñÿ äîïîëíèòåëüíàÿ êîíòðàöåïöèÿ â òå÷åíèè íåäåëè.
|